F225. LEVODOPA AUGMENTATION OF ANTIPSYCHOTICS FOR THE TREATMENT OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA

BACKGROUND: Negative symptoms (i.e., motivation deficits and diminished emotional expression) are prevalent in schizophrenia and consistently linked with functional impairment for affected individuals. Despite advances in psychopharmacology for schizophrenia, there remain no effective treatments for...

Descripción completa

Detalles Bibliográficos
Autores principales: Foussias, George, Rao, Naren, Fervaha, Gagan, Borlido, Carol, Haber, Lillian, Takeuchi, Hiroyoshi, Mizrahi, Romina, Remington, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887820/
http://dx.doi.org/10.1093/schbul/sby017.756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887820/
http://dx.doi.org/10.1093/schbul/sby017.756

Ejemplares similares